33 Isabel Tristn analyzed 80 serum and urine samples from COVID-19 patients (34 in intensive care and 46 hospitalized) and 32 healthy controls, identifying various metabolites, including TMAO, that could serve as biomarkers for the diagnosis, prognosis and severity assessment of COVID-19
For individuals living with complex chronic conditions like Long COVID, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and dysautonomia, the answer often lies deep within the cells
During inflammation, hepcidin levels rise and promote sequestration of serum iron into immune cells called macrophages
The differential metabolic requirements between cancerous and non-cancerous cells provides a therapeutic opportunity for regulating selective cellular immune responses
Glycyrrhizic acid rebalances mitochondrial dynamics to mitigate hepatotoxicity induced by triptolide